Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2009
08/27/2009WO2009105275A2 Human biomarkers for determining intrinsic b-cell defects
08/27/2009WO2009105269A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof
08/27/2009WO2009105256A2 Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand
08/27/2009WO2009105230A2 Methods for treating cancer using combination therapy
08/27/2009WO2009105192A2 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
08/27/2009WO2009105152A2 Virus-like particles as vaccines for paramyxovirus
08/27/2009WO2009104911A2 Uses as agents for prophylaxis or treatment of cervical cancer
08/27/2009WO2009104831A1 Use of mutant hiv-1 protease or siv protease as an adjuvant
08/27/2009WO2009104736A1 Antibody having affinity for amyloid plaque in tissue, and pharmaceutical composition comprising the same
08/27/2009WO2009104100A2 Antibody combinations, and methods of making and using same
08/27/2009WO2009104097A2 Meningococcal fhbp polypeptides
08/27/2009WO2009104074A2 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
08/27/2009WO2009103969A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
08/27/2009WO2009103828A1 Improved analytical method for the detection of latent hepatitis c, use thereof and corresponding diagnosis kit
08/27/2009WO2009103821A2 Means for treating virus infections
08/27/2009WO2009103538A1 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
08/27/2009WO2009103319A2 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases
08/27/2009WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
08/27/2009WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF
08/27/2009WO2009103160A1 Treatment and prevention of dry age-related macular degeneration by activating cd36
08/27/2009WO2009103157A1 Mfap4 as a marker for regulatory cells and anti-cancer cells
08/27/2009WO2009103133A1 Genetically modified sequences of trypanosoma cruzi ts and asp-2 antigens, recombinant ts and asp-2 proteins and genetically modified viruses that express the recombinant ts and asp-2 antigens
08/27/2009WO2009103113A1 HUMANIZED ANTI-C5aR ANTIBODIES
08/27/2009WO2009103105A2 Mimotope
08/27/2009WO2009083009A3 Monoclonal antibodies against cd32b
08/27/2009WO2009082440A3 Compositions of toll-like receptor agonists and malaria antigens and methods of use
08/27/2009WO2009077479A3 Altering high-density lipoprotein levels through carboxylesterase 1 modulation
08/27/2009WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
08/27/2009WO2009076455A3 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents
08/27/2009WO2009071860A3 G immunoglobulin used against anthrax toxins
08/27/2009WO2009043922A3 Extracellular targets for alzheimer's disease
08/27/2009WO2008141151A3 Synthetic herpes simplex viruses type-1 for treatment of cancers
08/27/2009US20090217402 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
08/27/2009US20090217401 Human Monoclonal Antibodies To Programmed Death 1(PD-1) And Methods For Treating Cancer Using Anti-PD-1 Antibodies Alone or in Combination with Other Immunotherapeutics
08/27/2009US20090217392 Anti- integrin antibodies, compositions, methods and uses
08/27/2009US20090216317 Delivery of Highly Lipophilic Agents Via Medical Devices
08/27/2009US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells
08/27/2009US20090215984 Conversion of apoptotic proteins
08/27/2009US20090215871 Simian adenovirus vectors and methods of use
08/27/2009US20090215722 Dextran; inhibit rejection of transplanted cells by the immune system of the recipient; gene therapy; saturating the antigen presenting cells (APC's) with nonimmunogenic agents; readily phagocytosed by APCs
08/27/2009US20090215691 NOGO Receptor Antagonists
08/27/2009US20090215151 Two-Step Immunization Procedure Against Chlamydia Infection
08/27/2009US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
08/27/2009US20090214666 Chitin microparticles and their medical uses
08/27/2009US20090214663 Virus coated nanoparticles and uses thereof
08/27/2009US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection
08/27/2009US20090214636 Imaging and Therapeutic Method Using Monocytes
08/27/2009US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies
08/27/2009US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
08/27/2009US20090214621 Electrostatic Patch For Allergen Screening And Applicator For Same
08/27/2009US20090214619 Implant for intraocular drug delivery
08/27/2009US20090214612 Extracellular tnf inhibitors for treating cns disorders
08/27/2009US20090214605 Hydrophilic Core Polymeric Micelles for the Delivery of Water-Soluble Compounds
08/27/2009US20090214597 Non-injection immunotherapy
08/27/2009US20090214596 Nasal Vaccine
08/27/2009US20090214595 Means for Obtaining Avirulent Leishmania Promastigotes, Promastigotes Obtained, and the Applications Thereof
08/27/2009US20090214594 Prevention and Treatment of Otitis Media with Non-Pathogenic Bacterial Strains
08/27/2009US20090214593 Immunogen platform
08/27/2009US20090214592 Adjuvant composition comprising aluminium phosphate and 3D-MPL
08/27/2009US20090214591 Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases
08/27/2009US20090214590 Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof
08/27/2009US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
08/27/2009US20090214588 Vaccines against aids comprising cmv/r-nucleic acid constructs
08/27/2009US20090214587 Recombinant virus and use thereof
08/27/2009US20090214586 Combination Vaccines With Whole Cell Pertussis Antigen
08/27/2009US20090214585 Medicament, Particularly an Anti-Cancer Medicament, for Treatment Using Immunotherapy, Particularly Autologous
08/27/2009US20090214584 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis
08/27/2009US20090214583 Epitope-enhancement of a human cd4 hiv epitope
08/27/2009US20090214582 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
08/27/2009US20090214581 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
08/27/2009US20090214580 Peptide mixtures with immunomodulatory activity
08/27/2009US20090214579 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
08/27/2009US20090214578 Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone
08/27/2009US20090214577 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
08/27/2009US20090214575 Annexin II and uses thereof
08/27/2009US20090214574 Anti-cd16 binding molecules
08/27/2009US20090214573 Modulation of bne development
08/27/2009US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
08/27/2009US20090214571 Colon cancer related gene tom34
08/27/2009US20090214570 Methods and compositions for immunizing against chlamydia infection
08/27/2009US20090214569 Use of HIV envelope/CD4 complexes for the generation antibodies
08/27/2009US20090214568 autoimmune vasculitis, graft versus host disease, multiple sclerosis, myasthenia gravis, and diabetes mellitus type I; time-release and sustained-release drugs
08/27/2009US20090214567 Immunoglobulin Fraction and Process Therefor
08/27/2009US20090214566 Protective anti-glucan antibodies with preference for beta-1,3- glucans
08/27/2009US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use
08/27/2009US20090214564 Anti-ephrinb2 antibodies and methods using same
08/27/2009US20090214563 Treatment for antiphospholipid-syndrome-related pregnancy complications
08/27/2009US20090214562 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
08/27/2009US20090214561 Treatment method
08/27/2009US20090214560 Binding molecules to the human ox40 receptor
08/27/2009US20090214559 Therapeutic Human Anti-IL-1R1 Monoclonal Antibody
08/27/2009US20090214558 NOVEL MAdCAM ANTIBODIES
08/27/2009US20090214557 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells
08/27/2009US20090214556 Antibodies and related molecules that bind to 161p2f10b proteins
08/27/2009US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases
08/27/2009US20090214554 Truncated memapsin 2 compositions and treatments
08/27/2009US20090214553 Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells
08/27/2009US20090214552 Novel Egg Receptors for Sperm Proteins
08/27/2009US20090214551 High Affinity Hiv T Cell Receptors
08/27/2009US20090214550 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy